Search research articles
Contact Us
Filters
Showing results (181-190 of 265) with videos related to
Page
of 27
Sort By:
Journal for Immunotherapy of Cancer
|
January 4, 2025
Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors
Julien Taieb, Margherita Ambrosini, Emily Alouani, et al.
Journal of Hematology & Oncology
|
July 3, 2026
KRAS inhibition is an effective therapy for appendiceal adenocarcinoma
Saikat Chowdhury, Ichiaki Ito, Vinay K Pattalachinti, et al.
JAMA Network Open
|
May 17, 2023
Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials
Marcus A Florez, Joseph Abi Jaoude, Roshal R Patel, et al.
The Oncologist
|
April 14, 2026
Mucinous histology and resistance to immune checkpoint blockade in patients with microsatellite instability-high metastatic colorectal cancer
Vincenzo Nasca, Margherita Ambrosini, Julien Taieb, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
January 6, 2025
Mutational and co-mutational landscape of early onset colorectal cancer
Jumanah Yousef Alshenaifi, Guglielmo Vetere, Giulia Maddalena, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 7, 2017
Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity
Randa Tao, Chiaojung Jillian Tsai, Garrett Jensen, et al.
Cancer Research Communications
|
May 6, 2024
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma
Nicholas J Hornstein, Mohammad A Zeineddine, Betul B Gunes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2022
Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142
T André, S Lonardi, K Y M Wong, et al.
The Oncologist
|
August 20, 2025
First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancer
Vincenzo Nasca, Gabriele Tinè, Julien Taieb, et al.
Molecular Cancer Therapeutics
|
May 5, 2017
Modeling of Patient-Derived Xenografts in Colorectal Cancer
Anastasia Katsiampoura, Kanwal Raghav, Zhi-Qin Jiang, et al.
Page
of 27
Search research articles
Search
Showing results (181-190 of 265) with videos related to
Sort By:
Page
of 27
Journal for Immunotherapy of Cancer
|
January 4, 2025
Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors
Julien Taieb, Margherita Ambrosini, Emily Alouani, et al.
Journal of Hematology & Oncology
|
July 3, 2026
KRAS inhibition is an effective therapy for appendiceal adenocarcinoma
Saikat Chowdhury, Ichiaki Ito, Vinay K Pattalachinti, et al.
JAMA Network Open
|
May 17, 2023
Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials
Marcus A Florez, Joseph Abi Jaoude, Roshal R Patel, et al.
The Oncologist
|
April 14, 2026
Mucinous histology and resistance to immune checkpoint blockade in patients with microsatellite instability-high metastatic colorectal cancer
Vincenzo Nasca, Margherita Ambrosini, Julien Taieb, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
January 6, 2025
Mutational and co-mutational landscape of early onset colorectal cancer
Jumanah Yousef Alshenaifi, Guglielmo Vetere, Giulia Maddalena, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 7, 2017
Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity
Randa Tao, Chiaojung Jillian Tsai, Garrett Jensen, et al.
Cancer Research Communications
|
May 6, 2024
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma
Nicholas J Hornstein, Mohammad A Zeineddine, Betul B Gunes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 28, 2022
Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142
T André, S Lonardi, K Y M Wong, et al.
The Oncologist
|
August 20, 2025
First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancer
Vincenzo Nasca, Gabriele Tinè, Julien Taieb, et al.
Molecular Cancer Therapeutics
|
May 5, 2017
Modeling of Patient-Derived Xenografts in Colorectal Cancer
Anastasia Katsiampoura, Kanwal Raghav, Zhi-Qin Jiang, et al.
Page
of 27